September 26, 2022

Litigation Risk Survey Finds Large In-House Workloads, Tight Resources and Missed Opportunities to Transfer Risk

Subscribe to Our Newsletter

Newsletter


Kevin Skrzysowski

|

September 26, 2022

Cover:

In-house legal departments say they are facing growing litigation burdens with limited staffing and financial resources—and yet most have not taken advantage of tools like risk transfer products to help manage workloads and ease budget uncertainty.

The 2022 Litigation Risk Survey, conducted by Risk Settlements in conjunction with In the House, asked general counsels and other in-house leaders around the globe about their litigation activities and legal spend, their tolerance for litigation risk, and their knowledge and use of the potential solutions available to help transfer the outcome risk of litigation.

The vast majority of in-house leaders—more than 80 percent—reported that their departments had 10 or fewer employees, and more than 70 percent said their legal budgets were less than $1 million. The results show that the size of the company and the size of the legal department do not necessarily correlate and provide further evidence that in-house lawyers and law departments are being stretched thin, particularly in the wake of the COVID-19 pandemic.

The survey also found that most in-house departments are bearing a substantial litigation workload. Three-quarters of respondents said they are currently defending active litigation, and 20 percent have 10 or more cases on the docket. Ten percent of respondents said they are fielding more than 50 active cases.

Perhaps unsurprisingly, given the tight budgets and small staffs, relatively few of the active cases are plaintiffs-side matters. Nearly half of respondents said they are currently pursuing no active affirmative litigation. And of the remaining respondents, the overwhelming majority are engaged in only a handful of plaintiffs-side matters.

In spite of their resource challenges, the majority of law departments have yet to take advantage of litigation risk transfer products. Most say, however, they are open to using them—particularly to gain greater budget certainty around costs. Two thirds of in-house counsel said they would consider using such products in their businesses in the future. This is especially true of products like litigation funding, adverse judgment insurance, and escrow release.

An effective claims monetization effort could assist GCs under pressure to transform their departments from cost centers into contributors to company profits. But less than a third of in-house leaders said their law departments are actively pursuing affirmative cases. If given the chance, however, nearly half—48 percent—would pursue claims if they were made aware of them, and 54 percent said they would be interested in pursuing affirmative cases regardless of the claim amount.

At present, most companies say they are attempting to locate affirmative claims themselves. Less than one-third are receiving help in identifying claims from outside counsel and only a handful are receiving the assistance of a litigation funder. The data suggests that companies should rely more heavily upon outside help to bring affirmative claims to their attention.

Nearly three-quarters of respondents said they were at least somewhat familiar with litigation funding. But only 5 percent say they have used funding themselves. In-house departments said they have identified funders primarily through referrals from business contacts. Half of the respondents reached out to funders directly or via funding brokers. Another third received referrals from outside counsel or were contacted by funders directly. An equal number of in- house counsel said the cost of funding and/or the structure of funding were the most important factors when choosing among funders.

Of the in-house counsel who have worked with a funder, the most common funding structure—used by 75 percent of respondents—was a contingency fee based upon the ultimate proceeds of a successful recovery. Hybrid structures, with claimants receiving funding via a combination of non-recourse loans and contingency fee arrangements, had also been used by two-thirds of respondents. Forty-four percent who have funded cases have arranged for a non-recourse loan, and 22 percent said they had used a recourse loan structure.

  • Legal Ops. Three-quarters of respondents said their companies did not yet have a legal operations team. And while much of the conversation in the legal industry has been about the role of legal ops in selecting outside counsel, respondents who have legal ops capabilities ranked outside counsel selection last among their key priorities. More important, they said, were finance, technology and strategic planning.
  • Litigation Risk. Fifty-four percent of respondents said they are “somewhat tolerant” of litigation risk. About a quarter of companies are “very tolerant” of risk. And a few—about 7 percent—say their companies are “extremely tolerant,” an answer that may suggest a few companies are leveraging affirmative litigation as a tool for revenue generation. Just over 16 percent—are “not tolerant at all” of litigation risk.
  • Outside Counsel. In-house lawyers surveyed said expertise in the litigation being defended is the most important factor in the hiring process for outside counsel. A prior relationship with the law firm (or their inclusion as panel counsel) ranks second, respondents said. While cost is a consideration, as is the law firm’s flexibility on fees, only 8 percent of in-house leaders said these issues were at the top of their list when making an outside counsel hiring decision.
  • Alternative Fee Arrangements. Alternative fee arrangements in litigation are occurring in about half (49 percent) of cases, the survey found. When they are used, AFAs are occurring more commonly in defense-side matters than in plaintiffs-side cases.
  • Liability Insurance. Companies commonly have commercial liability insurance, but it is rare for them to actually use it to cover litigation costs. By a wide margin, respondents said they relied upon insurance less than 10 percent of the time. Only one in four said they relied upon insurance policies to cover 50 percent or more of their litigation costs.
  • Assessing Risk. Assessing litigation risk remains a responsibility firmly in the hands of the general counsel, respondents said. Asked to rank the most important factors they use to assess risk in defense cases, in-house counsel said the “size of possible damages” and whether the matter is a “bet-the-company” case ranked first. The “likelihood of prevailing” in the case ranked second. When the company is considering bringing an action, however, the factors are reversed. By a wide margin, the likelihood of winning the case was the most important issue for in-house counsel when considering affirmative claims.

Responses to the 2022 Litigation Risk Survey came from in-house counsel in 20 countries, 37 U.S. states and the District of Columbia, and from more than 50 industry sectors.

Certum Group Can Help

Get in touch to start discussing options.

Recent Content

By Patrick Dempsey • October 27, 2026
This is the fifth post in Certum Group's seven-part series bringing our Trade Secret Litigation Playbook to the blog. It draws on Part V of the Playbook, Choosing Counsel and Structuring the Economics. Read or download the full Playbook here . The most common mistake I see claim holders make is also the most understandable one: they sign a law firm to a full contingency before they ever talk to a funder. A firm offering to take the whole case on contingency feels like a gift. You spend nothing, the firm carries the risk, and you share the upside only if you win. What could be wrong with that? When you look at cases side by side, quite a lot. A claim holder who engages a funder first and then hires counsel on a hybrid structure typically keeps substantially more of the recovery. To see why, start with the three ways to pay for a case. The three fee structures Hourly is the traditional model: you pay standard rates as the work is done, you own the outcome, and you bear 100% of the cost, win or lose. It fits deep-pocketed companies that want complete control, and smaller matters where alternative structures are hard to price. Full contingency puts the firm's fees entirely at risk, paid only from the recovery, usually at 33% to 40% of whatever comes in. It is attractive when you have limited capital, and the willingness of a good firm to take it is a genuine signal of merit. But it carries a real cost: that 30-to-40-percent-plus is meaningfully more than the combined economics of a hybrid or funded structure. Hybrid — shared risk — is the sweet spot for most matters between roughly $10 million and $250 million. The firm discounts its hourly rate, often steeply, in exchange for a smaller contingent premium on success. It preserves alignment while avoiding the full-contingency tax, and it becomes especially powerful when a funder pays the discounted fees, the claim holder pays nothing out of pocket, and counsel keeps meaningful upside. Why sequence changes the outcome Here is the part that sounds counterintuitive until you run the math. A 33-to-40-percent contingency leaves you with 60 to 67 cents of every recovery dollar. A hybrid structure — where counsel takes a smaller contingency, often 15 to 25 percent, layered on a discounted hourly fee that a funder pays — frequently leaves the claim holder with 50 to 65 percent after the funder's return, and sometimes more. The precise economics depend on the size and shape of the case, but the direction is robust: full contingency is rarely the cheapest path for a strong claim. Sequence matters because leverage is perishable. Once you sign a full-contingency engagement letter, the firm has effectively "bought" the case for its own investment committee, and switching firms afterward is expensive and awkward. With a funder in place and a hybrid structure available, you keep your optionality — you can hire the very best trial firm for your matter, rather than the best firm that happened to be willing to shoulder full risk. A funder's "no" is also valuable There is a quieter benefit, too. When a sophisticated institutional investor is willing to deploy non-recourse capital against your claim, that is one of the strongest external validations of case quality you can get, and counsel reads it that way. But even a decline is useful: it tells you where the weaknesses are — thin damages, a collectability problem, an identification gap — while you can still fix them, and before you have committed to a firm. Either way, you learn something you would rather know now than a year in. The sequence to consider In practice it looks like this. Retain trade secret counsel on a focused, limited-scope engagement to run an initial case assessment under privilege. While that is underway, open a confidential conversation with one or more funders, sharing the same materials. Use the funder's view — its willingness to fund, its read on damages, its suggested economics — to inform your choice of trial counsel. Then interview firms with that information in hand and propose a hybrid structure supported by the funder. Done well, the engagement letter, the funding agreement, and your preservation protocols can all be signed within the same week. None of this is a knock on contingency counsel, many of whom are excellent. It is simply a reminder that the cheapest-looking option at signing is often the most expensive one at resolution — and that a short conversation, before you sign anything, can be worth a large share of the recovery. Go deeper with the Playbook. This post covers one piece of a much larger picture. For the full framework — what the law requires, what a strong pre-filing case looks like, how damages experts value these matters, how counsel fee structures change your economics, and how litigation finance fits in — read Certum Group's Trade Secret Litigation Playbook , our field guide for business owners and the counsel who advise them: certumgroup.com/the-trade-secret-playbook . And if you are evaluating a live dispute — or simply want to pressure-test what a matter is worth and how it might be funded — get in touch. A confidential conversation with Certum is free and carries no obligation, whether or not you ultimately seek funding. Reach us at certumgroup.com/contact-us .
By Ross Weiner • October 21, 2026
A Connecticut state court has joined a long line of precedent holding that a litigant’s communications with a litigation funder are irrelevant and improper subjects of discovery. On October 19, 2026, the Connecticut Superior Court (Stamford) granted plaintiff Thomas Steffanci’s motion in limine and barred any evidence or argument about his litigation funding agreements at trial in Steffanci v. DFG Trademarks V, LLC (Docket No. FST-CV20-6045998-S). Judge Sheila Ann Ozalis found the agreements irrelevant, prejudicial, and unnecessary for the point defendants wanted to make. The dispute Steffanci moved to exclude his funding agreements as irrelevant to the claims and defenses in his upcoming trial, in which he is seeking at least $4 million in contract and fiduciary duty claims against his former employer. Defendants opposed on two grounds: Drafting intent. A central issue is whether the operative contract required amendments to be in writing. Defendants argued the funding agreements contain express written-amendment clauses, i.e., the kind Steffanci allegedly deleted from the LLC Agreement, showing he knew how to require a writing when he wanted one. Jury narrative. Defendants said the funding evidence was needed to rebut a misleading picture of a David vs. Goliath story. The court’s reasoning The court sided with plaintiff, finding that admitting the funding agreements for either purpose would be prejudicial and irrelevant to the claims and defenses. The decisive point was cumulativeness. Defendants did not need the funding agreements to show Steffanci knew how to draft a written-amendment requirement, because another contract at issue in the case (and admissible at trial) contains language “virtually identical” to the clauses defendants pointed to in the funding agreements. The order did not separately address the “corporate family” narrative argument beyond rejecting it as part of the overall relevance and prejudice finding. Why it matters The ruling adds to the line of decisions keeping litigation funding agreements away from juries absent a specific, case-tied need. The ruling also further supports the view that courts should not adopt procedural rules requiring the mandatory disclosure of litigation funding. Courts already have inherent power to require such disclosure if appropriate, and they usually find that disclosure is inappropriate. A few practical points for funders: Creative relevance theories still face a prejudice and necessity screen. Defendants offered a contract-interpretation rationale rather than a generic bias attack, and it still failed. Cumulative alternatives sink the argument. Where the same point can be made with an ordinary deal document already in evidence, courts have little reason to put the funding agreement in front of the jury. “David vs. Goliath” rebuttal arguments are not enough. The court did not accept that funding evidence is needed to balance a sympathetic plaintiff narrative. Boilerplate travels. Defendants’ theory rested on standard written-amendment clauses in the funding documents. Funded parties should expect opponents to mine funding agreements for drafting comparisons and be ready with an argument like the one that worked here. Steffanci v. DFG Trademarks V, LLC, No. FST-CV20-6045998-S (Conn. Super. Ct. Oct. 19, 2026) (Ozalis, J.) (order on Motion in Limine, Entry No. 892.00). Certum’s Model Brief Certum Group has published a model brief advising claimants and their counsel on how to resist discovery requests like those Steffanci faced in his Connecticut case. If you are interested in further reading on the discoverability of litigation finance agreements, click here to download the brief.
By Patrick Dempsey • October 13, 2026
This is the fourth post in Certum Group's seven-part series bringing our Trade Secret Litigation Playbook to the blog. It draws on Part IV of the Playbook, What Your Case Is Worth. Read or download the full Playbook here . Ask a business owner what a trade secret case is worth, and the first instinct is almost always the same: what did we lose? It is the intuitive measure, and it is usually the smallest one on the table. Trade secret law rewards claim holders who think about damages more expansively than "our lost sales," and the gap between the intuitive number and the recoverable number is often enormous. There are four measures worth understanding, and lost profits is only the first. Lost profits: what you would have earned The revenue you would have earned absent the misappropriation — contracts you would have signed, renewals you would have held, pricing power you could have sustained. Lost profits require you to prove causation between the taking and the foregone revenue, which is where most of the work goes. It is a real number, but it is anchored to your own historical performance, and that ceiling is frequently lower than what the case is actually worth. Unjust enrichment: what the defendant gained This is usually the largest measure, and by a wide margin. Unjust enrichment captures everything the defendant gained by taking the shortcut: the R&D and engineering it avoided, the head-start value of reaching the market faster than an independent developer could have, the savings and margins it captured, and — in the strongest cases — disgorgement of the revenue its product earned because it was built on your secret. In software, manufacturing, and pharmaceutical cases, the avoided-time-to-market term alone can dwarf your lost profits, because it measures the defendant's entire economic benefit rather than your specific loss. Reasonable royalty: the floor An objective measure grounded in what the defendant would have paid to license the secret in an arm's-length deal. It is typically the smallest of the three, but it functions as a floor when lost profits are speculative and unjust enrichment is contested. Sophisticated claim holders do not treat it as a fallback; they treat it as an independent anchor that constrains how small the number can reasonably be. Exemplary damages and fees: what willful conduct adds If the misappropriation was willful and malicious, the DTSA and most state statutes allow enhanced damages of up to twice the compensatory award, plus attorney's fees. 1 Willfulness is not a rhetorical flourish; it is a doubling, sometimes a tripling, of the core recovery. And the evidence that establishes it — an internal email, a board slide, a pattern of ignored warnings — is exactly the kind of material that discovery tends to surface. That is why intent belongs at the center of the case from day one. The Versata signal If you want a live illustration of how large the gap can be, look at the Federal Circuit's 2026 decision in Versata Software v. Ford. The trial court had tried to cap Versata's trade secret damages at a licensing-based model — essentially, what Ford would have paid — and zeroed out the rest as an undeserved "windfall." The Federal Circuit disagreed, holding that the DTSA's text expressly allows recovery of the unjust enrichment the defendant captured, even when that figure is far larger than any license fee. The message to corporate defendants is blunt: if you misappropriate rather than license, you assume the risk that the damages will dwarf what you could have paid. The message to claim holders is just as clear — the ceiling on your case is often much higher than your accountant's first estimate. Why this matters before you file Claim holders who engage a damages expert early consistently do better — not because the expert changes the facts, but because an early damages view changes three downstream decisions. It changes which counsel you hire, because the firms built for a $50 million case are different from the firms built for a $5 million case. It changes your fee structure, because a firm weighing a contingency needs a damages view to price it. And it changes settlement posture, because a plaintiff who can articulate a well-supported range anchors the negotiation, while one who cannot is negotiating against the defendant's number. The defendant almost always knows what you might get at trial. The only question is whether you do. Go deeper with the Playbook. This post covers one piece of a much larger picture. For the full framework — what the law requires, what a strong pre-filing case looks like, how damages experts value these matters, how counsel fee structures change your economics, and how litigation finance fits in — read Certum Group's Trade Secret Litigation Playbook , our field guide for business owners and the counsel who advise them: certumgroup.com/the-trade-secret-playbook . And if you are evaluating a live dispute — or simply want to pressure-test what a matter is worth and how it might be funded — get in touch. A confidential conversation with Certum is free and carries no obligation, whether or not you ultimately seek funding. Reach us at certumgroup.com/contact-us . Sources 1. 18 U.S.C. Section 1836(b)(3)(B) (permitting recovery of unjust enrichment not addressed in computing actual loss); Section 1836(b)(3)(C)-(D) (exemplary damages up to twice the compensatory award, and attorney's fees, for willful and malicious misappropriation).